Abstract
Ethnics and economics may affect prevalence and case fatality of Coronavirus disease 2019 (COVID-19). To determine whether COVID-19 prevalence and fatality are modulated by ethnics and economics, meta-regression of data from the countries in the New York metropolitan area were herein conducted. We selected 31 countries in the New York metropolitan area. 1) Prevalence and case-fatality rates of confirmed COVID-19 cases on May 20, 2020 and 2) income and poverty estimates were obtained in each country. We performed random-effects meta-regression using OpenMetaAnalys. The covariates included 1) black (%), 2) Hispanic or Latino (%), 3) poverty rates (%), and 4) median household income ($). Statistically significant (P < .05) covariates in the univariable model were together entered into the multivariable model. A slope (coefficient) of the univariable meta-regression line for COVID-19 prevalence was not significant for household income (P = .639), whereas the coefficient was significantly positive for black (coefficient, 0.021; P = .015), Hispanic/Latino (0.033; P < .001), and poverty (0.039; P = .02), which indicated that COVID-19 prevalence increased significantly as black, Hispanic/Latino, and poverty increased. The multivariable model revealed that the slope was significantly positive for only Hispanic/Latino (P < .001). The coefficient in the univariable model for COVID-19 fatality, however, was not significant for all the covariate. In conclusion, black, Hispanic/Latino, and poverty (not household income), especially Hispanic/Latino independently, may be associated with COVID-19 prevalence. There may be no association of black, Hispanic/Latino, poverty, and household income with COVID-19 fatality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No necessary IRB and/or ethics committee approvals have been obtained.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.